{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:49:43Z","timestamp":1781938183842,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R21HD105534"],"award-info":[{"award-number":["R21HD105534"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Current infant antiretroviral therapy formulations pose barriers to daily adherence due to complex weight-based dosing, conspicuous preparation, and poor palatability. These adherence barriers jeopardize adherence, making patients vulnerable to virologic failure, development of drug resistance, and preventable mortality. Our team has previously established proof-of-principle for multi-drug oral dissolvable strips as alternative pediatric antiretroviral formulations with the potential to overcome these challenges and improve pediatric ART adherence and outcomes. The objective of this study was to assess caregiver and provider preferences for oral dissolvable strips and its packaging to inform its development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Guided by concepts of user-centered design, we conducted key informant interviews with 30 HIV care providers and focus group discussions targeting caregivers of children\u2009&lt;\u200910 years of age living with HIV at 3 Kenyan hospitals. Key informant interviews and focus group discussions were audio recorded, translated\/transcribed verbatim, and hand coded for a-priori and emergent themes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 30 providers and 72 caregivers (caring for 83 children, aged 5 months to 18 years) participated in the study. Caregivers and providers expressed a strong desire for an easier way to administer medication, especially among children too young to swallow tablets whole, and expressed enthusiasm around the idea of oral dissolvable strips. Key preferences included a pleasant taste; one strip per dose; small size with rapid dissolution; clear markings and instructions; and no special storage requirements. For packaging, stakeholders preferred individually wrapped strips within a dispenser. The individual packaging should be durable, waterproof, and easy to dispose of in communal spaces. They should also be easy to open, with clear indications where to open. The packaging holding the strips should be durable, re-usable, accommodating of various refill frequencies, and easy to use for children as young as 6.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The concept of oral dissolvable strips was highly acceptable to caregivers of children living with HIV and HIV care providers. By engaging stakeholders in an iterative design process starting from the early phases of design and development, we will maximize the likelihood of developing a product that is acceptable to the caregiver and infant, therefore leading to sustainable adherence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-10078-6","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T17:02:13Z","timestamp":1697475733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing user preferences for design characteristics of oral dissolvable strips for pediatric HIV medication: a qualitative study"],"prefix":"10.1186","volume":"23","author":[{"given":"Catherine","family":"Wexler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Maloba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michala","family":"Sliefert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadrack","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicodemus","family":"Maosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Maliski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Were","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Mbithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mugendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshdeep","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Finocchario-Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"issue":"1","key":"10078_CR1","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/S2214-109X(19)30448-6","volume":"8","author":"AL Slogrove","year":"2020","unstructured":"Slogrove AL, Powis KM, Johnson LF, Stover J, Mahy M. Estimates of the global population of children who are HIV-exposed and uninfected, 2000-18: a modelling study. Lancet Glob Health. 2020;8(1):e67\u2013e75.","journal-title":"Lancet Glob Health"},{"key":"10078_CR2","unstructured":"UNICEF. Global and regional trends 2022 [Available from: https:\/\/data.unicef.org\/topic\/hivaids\/global-regional-trends\/."},{"key":"10078_CR3","unstructured":"UNAIDS. UNAIDS Data 2021. 2021."},{"key":"10078_CR4","unstructured":"National AIDS, and STI Control Programme. Kenya Population-based HIV Impact Assessment Nairobi, Kenya2018."},{"issue":"4","key":"10078_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/QAD.0000000000000559","volume":"29","author":"MP Fox","year":"2015","unstructured":"Fox MP, Rosen S. Systematic review of retention of pediatric patients on HIV treatment in low and middle-income countries 2008\u20132013. Aids. 2015;29(4):493\u2013502.","journal-title":"Aids"},{"key":"10078_CR6","first-page":"1654938","volume":"2016","author":"AF Schlatter","year":"2016","unstructured":"Schlatter AF, Deathe AR, Vreeman RC. The need for Pediatric Formulations to treat children with HIV. AIDS Res Treat. 2016;2016:1654938.","journal-title":"AIDS Res Treat"},{"key":"10078_CR7","unstructured":"Sliefert M, Maloba M, Wexler C, Maliski E, Nicolay Z, Were F et al. Assessing Challenges to Pediatric ART Provision: a qualitative study. AIDS Behav. Under Review."},{"issue":"4","key":"10078_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11904-009-0026-8","volume":"6","author":"J Haberer","year":"2009","unstructured":"Haberer J, Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr HIV\/AIDS Rep. 2009;6(4):194\u2013200.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"11","key":"10078_CR9","doi-asserted-by":"publisher","first-page":"e1002183","DOI":"10.1371\/journal.pmed.1002183","volume":"13","author":"Z Shubber","year":"2016","unstructured":"Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. Patient-reported barriers to adherence to antiretroviral therapy: a systematic review and Meta-analysis. PLoS Med. 2016;13(11):e1002183.","journal-title":"PLoS Med"},{"key":"10078_CR10","doi-asserted-by":"crossref","unstructured":"Dahmash EZ, Iyire A, Alyami HS. Development of orally dissolving films for pediatric-centric administration of anti-epileptic drug topiramate \u2013 A design of experiments (DoE) study. Saudi Pharm J. 2021.","DOI":"10.1016\/j.jsps.2021.04.025"},{"issue":"2","key":"10078_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1208\/s12249-015-0313-1","volume":"16","author":"M Preis","year":"2015","unstructured":"Preis M. Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use. AAPS PharmSciTech. 2015;16(2):234\u201341.","journal-title":"AAPS PharmSciTech"},{"key":"10078_CR12","unstructured":"Finocchario-Kessler S, Hageman M, Nicolay Z, Wang Z, Wexler C, Maliski E. Pediatric Prophylactic antiretroviral oral Dissolvible Strip Formulation: Proof of Principle. BMC Research Notes. Under Review."},{"key":"10078_CR13","unstructured":"Ministry of Health. Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV infection in Kenya. 2018."},{"issue":"5","key":"10078_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s13346-017-0397-0","volume":"7","author":"KM Guthrie","year":"2017","unstructured":"Guthrie KM, Rosen RK, Vargas SE, Guillen M, Steger AL, Getz ML, et al. User input in iterative design for prevention product development: leveraging interdisciplinary methods to optimize effectiveness. Drug Deliv Transl Res. 2017;7(5):761\u201370.","journal-title":"Drug Deliv Transl Res"},{"issue":"16","key":"10078_CR15","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s40265-014-0297-2","volume":"74","author":"F Liu","year":"2014","unstructured":"Liu F, Ranmal S, Batchelor HK, Orlu-Gul M, Ernest TB, Thomas IW, et al. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs. 2014;74(16):1871\u201389.","journal-title":"Drugs"},{"issue":"5","key":"10078_CR16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1208\/s12248-016-9938-6","volume":"18","author":"S Stegemann","year":"2016","unstructured":"Stegemann S, Ternik RL, Onder G, Khan MA, van Riet-Nales DA. Defining patient Centric Pharmaceutical Drug Product Design. Aaps j. 2016;18(5):1047\u201355.","journal-title":"Aaps j"},{"issue":"3","key":"10078_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.foodqual.2004.05.012","volume":"16","author":"E van Kleef","year":"2005","unstructured":"van Kleef E, van Trijp HCM, Luning P. Consumer research in the early stages of new product development: a critical review of methods and techniques. Food Qual Prefer. 2005;16(3):181\u2013201.","journal-title":"Food Qual Prefer"},{"issue":"23","key":"10078_CR18","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1001\/jama.2015.15818","volume":"314","author":"NL Hunter","year":"2015","unstructured":"Hunter NL, O\u2019Callaghan KM, Califf RM. Engaging patients across the Spectrum of Medical Product Development: View from the US Food and Drug Administration. JAMA. 2015;314(23):2499\u2013500.","journal-title":"JAMA"},{"issue":"1","key":"10078_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40900-018-0093-3","volume":"4","author":"M Chalasani","year":"2018","unstructured":"Chalasani M, Vaidya P, Mullin T. Enhancing the incorporation of the patient\u2019s voice in drug development and evaluation. Res Involv Engagem. 2018;4(1):10.","journal-title":"Res Involv Engagem"},{"issue":"6","key":"10078_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1517\/17460441.2015.1037271","volume":"10","author":"M Allarakhia","year":"2015","unstructured":"Allarakhia M. Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement. Expert Opin Drug Discov. 2015;10(6):571\u20138.","journal-title":"Expert Opin Drug Discov"},{"issue":"Suppl 1","key":"10078_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/QAI.0000000000001743","volume":"78","author":"M Penazzato","year":"2018","unstructured":"Penazzato M, Irvine C, Vicari M, Essajee SM, Sharma A, Puthanakit T, et al. A Global Research Agenda for Pediatric HIV. J Acquir Immune Defic Syndr. 2018;78(Suppl 1):10\u2013s5.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10078_CR22","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S2352-3018(18)30005-5","volume":"5","author":"M Penazzato","year":"2018","unstructured":"Penazzato M, Watkins M, Morin S, Lewis L, Pascual F, Vicari M, et al. Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action. Lancet HIV. 2018;5(5):e259\u2013e64.","journal-title":"Lancet HIV"},{"key":"10078_CR23","unstructured":"National Institutes of Health. Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01). Eunice Kennedy Shriver National Institute of Child Health and Human Development, editor.; 2018."},{"key":"10078_CR24","volume-title":"Paediatric antiretroviral drug optimization (PADO) meeting 4","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Paediatric antiretroviral drug optimization (PADO) meeting 4. Switzerland: Geneva; 2018."},{"issue":"8","key":"10078_CR25","doi-asserted-by":"publisher","first-page":"e0220408","DOI":"10.1371\/journal.pone.0220408","volume":"14","author":"A Nebot Giralt","year":"2019","unstructured":"Nebot Giralt A, N\u00f6stlinger C, Lee J, Salami O, Lallemant M, Onyango-Ouma W, et al. Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV\/r)\u2014A realist evaluation. PLoS ONE. 2019;14(8):e0220408.","journal-title":"PLoS ONE"},{"issue":"9","key":"10078_CR26","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1016\/S2352-3018(19)30193-6","volume":"6","author":"M Penazzato","year":"2019","unstructured":"Penazzato M, Townsend CL, Rakhmanina N, Cheng Y, Archary M, Cressey TR, et al. Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list. The Lancet HIV. 2019;6(9):e623\u2013e31.","journal-title":"The Lancet HIV"},{"issue":"10","key":"10078_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/apc.2011.0083","volume":"25","author":"BC Fetzer","year":"2011","unstructured":"Fetzer BC, Mupenda B, Lusiama J, Kitetele F, Golin C, Behets F. Barriers to and facilitators of adherence to Pediatric Antiretroviral Therapy in a sub-saharan setting: insights from a qualitative study. AIDS Patient Care STDS. 2011;25(10):611\u201321.","journal-title":"AIDS Patient Care STDS"},{"key":"10078_CR28","doi-asserted-by":"crossref","unstructured":"Wexler C, Nazir N, Gautney B, Maloba M, Brown M, Goggin K et al. Predictors of early ART initiation among HIV + Infants in Kenya: a retrospective review of HITSystem Data from 2013 to 2017. Matern Child Health J. 2020;24.","DOI":"10.1007\/s10995-020-02909-3"},{"key":"10078_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.","journal-title":"Implement Sci"},{"key":"10078_CR30","doi-asserted-by":"crossref","unstructured":"Odeny TA, Padian N, Doherty MC, Baral S, Beyrer C, Ford N et al. Definitions of implementation science in HIV\/AIDS. The lancet HIV. 2015;2(5):e178-80.","DOI":"10.1016\/S2352-3018(15)00061-2"},{"issue":"1","key":"10078_CR31","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1186\/s12913-018-3739-9","volume":"18","author":"V Mochache","year":"2018","unstructured":"Mochache V, Irungu E, El-Busaidy H, Temmerman M, Gichangi P. Our voices matter: a before-after assessment of the effect of a community-participatory intervention to promote uptake of maternal and child health services in Kwale, Kenya. BMC Health Serv Res. 2018;18(1):938.","journal-title":"BMC Health Serv Res"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10078-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-10078-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10078-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T14:33:35Z","timestamp":1700318015000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-10078-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["10078"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-10078-6","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"20 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were approved by Institutional Review Boards at the University of Kansas Medical Center (STUDY00147024) and the University of Nairobi Ethics and Review Committee (P457\/06\/2021). All methods were carried out in accordance with relevant guidelines and regulations. All participants completed a written informed consent prior to participating in the study. The informed consent process was designed to appropriately inform both literate and illiterate participants about the study, including the purpose and potential benefits and risks. A Mentor Mother or study team member walked each client through the informed consent document. Prior to a request for written informed consent, participants were asked to summarize what they\u2019ve been told\/read to ensure comprehension and were given the opportunity to ask questions. Participants who were non-literate were given the option of using a thumb-print in lieu of a signature for study consent. These informed consent procedures were approved by the Institutional Review Boards at the University of Kansas Medical Center and the University of Nairobi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Edward Maliski is the majority owner of Oak Therapeutics and co-inventor of US Patent Application16\/630,638 (Pat. Pend.) All other authors declare they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1103"}}